Ken Fisher
MIRM icon

Ken Fisher’s Mirum Pharmaceuticals MIRM Stock Holding History

Ken Fisher’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.6M Buy
93,109
+79,020
+561% +$7.43M ﹤0.01% 408
2025
Q4 		$1.11M Buy
+14,089
New +$1.01M ﹤0.01% 658

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ken Fisher's MIRM Position: Q1 2026 in Review

Ken Fisher increased its Mirum Pharmaceuticals (MIRM) stake by 561% in Q1 2026, buying an estimated $7.43M and bringing the position to 93,109 shares worth $8.6M. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Ken Fisher first reported a position in MIRM in Q4 2025 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Ken Fisher held 93,109 shares of Mirum Pharmaceuticals worth $8.6M as of Q1 2026.
  • Ken Fisher bought 79,020 Mirum Pharmaceuticals shares in Q1 2026, an estimated $7.43M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #408 holding.
  • Ken Fisher first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.